
Heavy drinking and your brain; patients taking Ozempic for T1D; memory-inspired AI – Morning Medical Update
Key Takeaways
- Heavy drinking is linked to increased risk of brain damage, including vascular lesions and Alzheimer's-related tau tangles, with effects persisting post-cessation.
- GLP-1 medication use has risen 800% among type 1 diabetes patients, despite limited safety data, necessitating further randomized trials.
The top news stories in medicine today.
People who have eight or more drinks per week may be at higher risk for brain damage, including vascular lesions and Alzheimer’s-related tau tangles, according to a new study published in
Despite limited data regarding its safety, more people with type 1 diabetes are using medications like Ozempic and Mounjaro — originally designed for type 2. A Johns Hopkins study found an 800% rise in GLP-1 use among adults with obesity from 2008 to 2023. Although some patients report big benefits, researchers stress the need for randomized trials to understand risks like severe low blood sugar.
A new study introduces “machine memory intelligence” (M2I), a brain-inspired framework that mimics how humans store and retrieve information. Published in
Newsletter
Stay informed and empowered with Medical Economics enewsletter, delivering expert insights, financial strategies, practice management tips and technology trends — tailored for today’s physicians.



















